Company Filing History:
1 out of 1,332 
1 out of 525 
Years Active: 2005
Title: The Innovations of Colin Lesley Ward: A Focus on EGF Receptor Modulation
Introduction: Colin Lesley Ward is an accomplished inventor based in Carlton, Australia. With a focused expertise in molecular design, he holds a notable patent that contributes significantly to the field of biochemistry and pharmaceuticals. His work has implications for understanding and manipulating the EGF receptor family, which plays a crucial role in various biological processes.
Latest Patents: Colin Ward’s patent, titled "Method of designing agonists and antagonists to EGF receptor family," presents a groundbreaking approach to the design of compounds that can bind to the EGF receptor family molecules. This patent not only emphasizes the importance of three-dimensional structural coordinates in drug design but also opens pathways for developing new therapeutic agents to modulate receptor activity, thereby aiding in the treatment of diseases.
Career Highlights: Throughout his career, Colin Ward has collaborated with esteemed organizations such as the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the Ludwig Institute for Cancer Research Limited. His tenure at these institutions has provided him with a platform to advance his research and contribute valuable insights to the scientific community.
Collaborations: Collaboration is a significant aspect of Colin Ward's career. He has worked alongside talented individuals including Thomas Charles Elleman and Vidanagamage Chandana Epa. These partnerships have enhanced his research efforts and facilitated innovations that address complex biological challenges.
Conclusion: Colin Lesley Ward exemplifies the spirit of innovation within the realm of biochemistry. His contributions, notably through his patent on EGF receptor modulation, showcase the importance of targeted research and collaboration in advancing scientific knowledge and therapeutic solutions. As the fields of biotechnology and pharmacology continue to evolve, Ward's work remains a valuable asset to both academia and industry.